Skip to main content
. 2024 Apr 10;16(4):2314–2325. doi: 10.21037/jtd-23-1752

Table 2. Morbidity and mortality of 198 patients.

Variable Total (N=198) GIB group (N=38) Control group (N=160) t2 P
Mortality, n (%) 15 (7.6) 10 (26.3) 5 (3.1) 23.586 <0.001
Hospital stays (days)* 22 [17–33] 25 [17–37] 22 [17–32] 0.21
ICU stay (days)* 8 [5–14] 15 [8–25] 7 [5–12] <0.001
Ventilation duration (h)* 96 [39–168] 168 [120–372] 71 [34–148] <0.001
Reintubation, n (%) 25 (12.6) 13 (34.2) 12 (7.5) 19.859 <0.001
Pulmonary infection, n (%) 76 (38.4) 19 (50.0) 57 (35.6) 2.683 0.10
Bloodstream infection, n (%) 7 (3.5) 4 (10.5) 3 (1.9) 6.739 0.009
AKI-KDIGO grade, n (%) 42.099 <0.001
   None 87 (43.9) 7 (18.4) 80 (50.0) 12.431 <0.001
   Grade 1 36 (18.2) 4 (10.5) 32 (20.0) 1.853 0.17
   Grade 2 35 (17.7) 5 (13.2) 30 (18.8) 0.660 0.41
   Grade 3 40 (20.2) 22 (57.9) 18 (11.3) 41.444 <0.001
CRRT, n (%) 34 (17.2) 19 (50.0) 15 (9.4) 35.631 <0.001

*, continuous variables are presented as median with interquartile ranges [IQR] for data with large SD or non-normal distributions. GIB, gastrointestinal bleeding; ICU, intensive care unit; AKI, acute kidney injury; KDIGO, Kidney Disease: Improving Global Outcomes; CRRT, continuous renal replacement therapy; SD, standard deviation.